These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17337498)

  • 1. Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.
    Maynard JD; Rohrscheib M; Way JF; Nguyen CM; Ediger MN
    Diabetes Care; 2007 May; 30(5):1120-4. PubMed ID: 17337498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive skin fluorescence spectroscopy is comparable to hemoglobin A1c and fasting plasma glucose for detection of abnormal glucose tolerance.
    Olson BP; Matter NI; Ediger MN; Hull EL; Maynard JD
    J Diabetes Sci Technol; 2013 Jul; 7(4):990-1000. PubMed ID: 23911181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).
    Perry RC; Shankar RR; Fineberg N; McGill J; Baron AD;
    Diabetes Care; 2001 Mar; 24(3):465-71. PubMed ID: 11289469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India.
    Kumpatla S; Aravindalochanan V; Rajan R; Viswanathan V; Kapur A
    Diabetes Res Clin Pract; 2013 Oct; 102(1):60-4. PubMed ID: 24035281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
    Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
    Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of A1C, fasting and 2-h post-load plasma glucose criteria to diagnose diabetes in Italian Caucasians.
    Marini MA; Succurro E; Arturi F; Ruffo MF; Andreozzi F; Sciacqua A; Lauro R; Hribal ML; Perticone F; Sesti G
    Nutr Metab Cardiovasc Dis; 2012 Jul; 22(7):561-6. PubMed ID: 21944738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive type 2 diabetes screening: clinical evaluation of SCOUT DS in an Asian Indian cohort.
    Mohan V; Rani CS; Regin BS; Balasubramanyam M; Anjana RM; Matter NI; Poongothai S; Deepa M; Pradeepa R
    Diabetes Technol Ther; 2013 Jan; 15(1):39-45. PubMed ID: 23150995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting plasma glucose in screening for NIDDM in the U.S. and Israel.
    Modan M; Harris MI
    Diabetes Care; 1994 May; 17(5):436-9. PubMed ID: 7741837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
    Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
    Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of high-normal levels of haemoglobin A(1C) and fasting plasma glucose for diabetes screening and for prediction: a meta-analysis.
    Kodama S; Horikawa C; Fujihara K; Hirasawa R; Yachi Y; Yoshizawa S; Tanaka S; Sone Y; Shimano H; Iida KT; Saito K; Sone H
    Diabetes Metab Res Rev; 2013 Nov; 29(8):680-92. PubMed ID: 23963843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of a combination of hemoglobin A(1c) and fasting plasma glucose in population-based prediabetes screening.
    Okosun IS; Davis-Smith M; Paul Seale J; Ngulefac J
    J Diabetes; 2012 Dec; 4(4):407-16. PubMed ID: 22268513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated Hemoglobin Is Suboptimal for the Screening of Prediabetes and Type 2 Diabetes in Adults With Nonalcoholic Fatty Liver Disease.
    Gignac T; Trépanier G; Paquet V; Ferland S; Carreau AM
    Can J Diabetes; 2023 Oct; 47(7):603-610. PubMed ID: 37352972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
    Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
    Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience.
    Colagiuri S; Hussain Z; Zimmet P; Cameron A; Shaw J;
    Diabetes Care; 2004 Feb; 27(2):367-71. PubMed ID: 14747215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative type 2 diabetes screening tests may reduce the number of U.S. adults with undiagnosed diabetes.
    Dadwani RS; Skandari MR; GoodSmith MS; Phillips LS; Rhee MK; Laiteerapong N
    Diabet Med; 2020 Nov; 37(11):1935-1943. PubMed ID: 32449198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria.
    Rosella LC; Lebenbaum M; Fitzpatrick T; Zuk A; Booth GL
    Diabetes Care; 2015 Jul; 38(7):1299-305. PubMed ID: 25852207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.
    Narayan KM; Hanson RL; Pettitt DJ; Bennett PH; Knowler WC
    Diabetes Care; 1996 Sep; 19(9):972-8. PubMed ID: 8875091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c.
    Lipska KJ; De Rekeneire N; Van Ness PH; Johnson KC; Kanaya A; Koster A; Strotmeyer ES; Goodpaster BH; Harris T; Gill TM; Inzucchi SE
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5289-95. PubMed ID: 20861123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of fasting plasma glucose values for optimal detection of abnormal responses on the oral glucose tolerance test in at-risk study subjects.
    Robles-Osorio L; Aguilar-Salinas CA; Mehta R; Gómez-Pérez FJ; Rull JA
    Endocr Pract; 2007 Oct; 13(6):583-9. PubMed ID: 17954413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.